India’s pharma regulatory failures point to a deeper structural flaw

The Three Ds: Navigating De-globalization, De-risking, and Deregulation
October 2, 2025
Cost of living: Should India’s tracker of retail inflation account for free food handouts under PMGKAY?
November 6, 2025

Policy and Media

India’s pharma regulatory failures point to a deeper structural flaw

October 24, 2025

    The recent tragedy of the contaminated cough syrups, leading to heartbreaking and avoidable deaths of children both here and abroad is not an isolated incident. It is merely the latest, most horrific symptom in a continuing and distressingly predictable series of regulatory failures that plague India’s health sector. When one drills down, the pathology is not just in the failed product or the rogue manufacturer; it’s lodged deep in the very design of the regulatory machinery intended to protect the public.


    Related Posts